Detection and characterization of antibiotic resistance plasmids in Cheney biosolids by Paramasivam, Gaayathiri
Eastern Washington University
EWU Digital Commons
EWU Masters Thesis Collection Student Research and Creative Works
2013
Detection and characterization of antibiotic
resistance plasmids in Cheney biosolids
Gaayathiri Paramasivam
Eastern Washington University
Follow this and additional works at: http://dc.ewu.edu/theses
This Thesis is brought to you for free and open access by the Student Research and Creative Works at EWU Digital Commons. It has been accepted for
inclusion in EWU Masters Thesis Collection by an authorized administrator of EWU Digital Commons. For more information, please contact
jotto@ewu.edu.
Recommended Citation
Paramasivam, Gaayathiri, "Detection and characterization of antibiotic resistance plasmids in Cheney biosolids" (2013). EWU Masters
Thesis Collection. 241.
http://dc.ewu.edu/theses/241
 
 
 
DETECTION AND CHARACTERIZATION OF ANTIBIOTIC RESISTANCE PLASMIDS IN 
CHENEY BIOSOLIDS 
             
 
A Thesis 
Presented To 
Eastern Washington University 
Cheney, Washington 
             
 
In Partial Fulfillment of the Requirements 
For the Degree 
Biology (Master of Science) 
             
 
By 
Gaayathiri Paramasivam 
Winter 2013 
  
 
 
ii 
 
 
  
 
THESIS OF GAAYATHIRI PARAMASIVAM APPROVED BY 
 
 
 
 
 
 
 
         DATE   
 DR. PRAKASH BHUTA, GRADUATE STUDY COMMITTEE 
 
 
 
        DATE   
 DR. ANDREA CASTILLO, GRADUATE STUDY COMMITTEE 
 
 
 
        DATE   
 DR. LAVONA REEVES, GRADUATE STUDY COMMITTEE 
 
 
 
 
 
 
 
 
iii 
 
 
 
 
MASTER’S THESIS 
 
 
In presenting this thesis in partial fulfillment of the requirements for a master’s degree 
at Eastern Washington University, I agree that the JFK Library shall make copies freely 
available for inspection. I further agree that copying of this project in whole or in part is 
allowable only for scholarly purposes. It is understood, however, that any copying or 
publication of this thesis for commercial purposes, or for financial gain, shall not be 
allowed without my written permission. 
 
 
 
 
 
Signature     
 
Date      
 
  
 
 
iv 
 
ABSTRACT 
 
     Biosolids are organic matter produced at the end of sewage treatment process. It has 
been shown that during sewage treatment, resistant bacteria are selected because of 
the presence of antibiotics and their byproducts. These resistant bacteria are more likely 
to transfer resistance genes to other bacteria. In the current study, we examined 
Cheney biosolids for the presence of drug resistant bacteria and the role of these 
bacteria in transfer of resistance genes to others. We screened 100 bacteria for drug 
resistance and found that 68% of the isolates were resistant to two or more drugs 
tested. Plasmids were separated from the resistant bacteria and 13.2% of them showed 
the presence of plasmids. These resistance plasmids were introduced into E. coli MM294 
to screen for the presence of antibiotic resistance genes. Plasmids were isolated from 
the transformants and 77.7% of the transformants showed the presence of plasmids 
with similar size and mobility on an agarose gel. The plasmids extracted from the 
transformants were digested with a restriction enzyme, EcoRI to verify the presence of 
multiple plasmids in the samples. The resistant bacteria (13.2%) that showed the 
presence of plasmid were tested whether they were conjugative or mobilizable type. 
Unfortunately, none of the isolates were conjugative or mobilizable plasmid. In short, 
Cheney biosolids do contain drug resistant bacteria, so there is a chance that these 
resistant bacteria will transfer their resistance genes to other bacteria present in 
biosolids.  
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1. Introduction: 
1.1 Significance of Antibiotics: 
     Antibiotics are chemicals that restrict the growth of bacteria. They are divided into 
two major categories based on their effect on a target cell: bacteriostatic (growth 
inhibitor) and bactericidal (killing agent) (Davies, 2010; Walsh, 2003). Antibiotics affect 
bacterial growth by many different mechanisms including: 1. disruption of bacterial cell 
wall (e.g., Penicillin), 2. inhibition of protein synthesis (e.g., Aminoglycosides and 
Tetracyclines), and 3. inhibition of DNA replication and transcription (e.g., Quinolones 
and Rifampin). The most commonly used antibiotics and those used in this study are 
listed in Table 1. Antibiotics are used everywhere - in agriculture, aquaculture, livestock, 
veterinary and human treatment. From the 1950s, antibiotics such as oxytetracycline 
and streptomycin have been used as pesticides when growing fruit, vegetable, and 
ornamental plants. Streptomycin is primarily used for control of fire blight in apples, 
pears and plants of the Rosaceae family. In the USA, approximately 10,000 tons of 
antibiotics are used on plants (McManus et al., 2002). Animal farms and aquaculture are 
also using antibiotics to promote growth and prevent diseases (Cabello, 2006). For 
example, in swine breeding farms, antibiotics are detected in dust from the air 
ventilators (Hamscher et al., 2003). It has been shown that antibiotic misuse or overuse 
has resulted in the development of drug resistant bacteria in the environment (Rhodes 
et al., 2000). Such resistant bacteria pass  
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on their resistance traits to successive generations (vertical transmission) and to other 
members of the bacterial community (horizontal gene transfer) (Davies, 2010; 
Freifelder, 1987).  
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Table 1: Antibiotics: classes, targets and resistance mechanisms   
 
Class / Generic 
name 
 
Common uses Target Resistance Mechanism 
Aminoglycosides 
Kanamycin 
 
 
Streptomycin 
E. coli, Klebsiella, 
Pseudomonas 
infections 
 
Anti-tuberculosis 
Binds to 30S 
subunit of bacterial 
ribosome, thereby 
inhibits protein 
synthesis 
Phosphorylation, 
acetylation, 
nucleotidylation, drug 
efflux and target 
alteration 
Penicillin 
 
Ampicillin 
Streptococcal 
infections, 
Syphilis, and 
Lyme disease 
Disrupts the 
peptidoglycan layer 
of bacterial cell 
wall 
Hydrolysis, drug efflux 
and target alteration 
Quinolones 
 
Nalidixic acid 
 
Ciprofloxacin 
 
Urinary tract 
infections, 
pneumonia, 
bacterial 
diarrhea, and 
mycoplasmal 
infections 
Bind to DNA gyrase 
A, thereby inhibits 
DNA replication 
and transcription 
Gyrase mutations, 
reduced uptake and 
drug efflux 
Tetracyclines 
 
 
 
Tetracycline 
 
 
Syphilis, Lyme 
disease and 
mycoplasmal 
infections 
(also used to 
treat infections 
in plants and 
animals) 
Binds to 30S 
subunit of bacterial 
ribosome, thereby 
inhibits protein 
synthesis 
Monooxygenation, 
drug efflux and target 
alteration 
Others 
 
Rifampin 
Gram positive 
and 
mycobacteria 
Binds to the β 
subunit of RNA 
polymerase and  
inhibits 
transcription 
ADP-ribosylation, 
drug efflux and target 
alteration 
Chloramphenicol 
(rarely used in the 
U.S) 
Meningitis, 
MRSA, topical 
use, or for low 
cost internal 
treatment. 
 
Inhibits bacterial 
protein synthesis 
by binding to the 
50S subunit of the 
ribosome 
Acetylation, drug 
efflux and target 
alteration 
1.2 Issues with Drug Resistant Bacteria: 
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     In 1928, Alexander Fleming discovered the first naturally occuring antibiotic, 
penicillin. In the 1940s, even before the introduction of penicillin into clinical practice, a 
bacterial enzyme penicillinase was discovered. Penicillinase breaks down penicillin by 
targeting the β-lactam ring present in its structure (Abraham and Chain, 1940). 
Antibiotic producing bacteria and fungi developed natural resistance to protect 
themselves from the antibiotics that they produce. This shows the prevalance of 
antibiotic resistance in natural settings (Walsh, 2003). However, introduction of 
antibiotics in clinical practice has created enormous pressure on bacteria and selected 
them for drug resistance. A strong correlation between the use of antibiotics and a 
development of resistance has been observed over the past half-century (Shlaes et al., 
1997). This is especially true for β-lactam class of antibiotics and their corresponding 
inactivating enzyme, β-lactamases (Damoa-Siakwan, 2005; Shlaes et al., 1997). At this 
time, several classes of β-lactamases have been identified, comprising up to 1000 
different β-lactamases (Bush and Jacoby, 2010). The use of antibiotics worldwide in 
clinical practice has led to multidrug resistant (MDR) and extensively drug resistant 
(XDR) strains of bacteria e.g., MDR and XDR Mycobacterium tuberculosis (Gandhi et al., 
2006 and Sekiguchi et al., 2007). The Centers for Disease Control and Prevention (CDC, 
2008) estimate the annual cost of treating infections caused by drug resistant bacteria 
to be 5.7 to 6.8 billion U.S. dollars. This shows the persistence of drug resistance in 
bacterial populations.  
     The resistance genes that confer antibiotic resistance are prevalent and widespread 
among bacterial communities because of horizontal gene transfer (HGT) (Shlaes et al., 
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1997). The HGT mechanisms include: 1. transformation (cell free DNA uptake), 2. 
conjugation (bacterial mating) and 3. transduction (viral infection). These mechanisms 
have played a significant role in the evolution and transmission of β-lactam resistance 
among bacteria. For instance, Pseudomonas aeruginosa became resistant to β-lactams 
and aminoglycosides (another class of antibiotics), thus evolved into a life threating 
pathogen. Patients with cystic fibrosis are most susceptible to P. aeruginosa as this 
pathogen is highly opportunistic and infect damaged tissues by avoiding human immune 
defenses (Curran et al., 2004; Horrevorts et al., 1990).  
     Similarly, a gram-negative pathogen, Acinetobacter baumnanni is primarily hospital 
acquired (nosocomial) causing serious infections and death (Peleg et al., 2008). These 
organisms persist in soil and water. Several Acinetobacters are resistant to various 
classes of drugs such as β-lactams, aminoglycosides, quinolones and tetracyclines. In 
addition, many Acinetobacters are naturally competent for DNA uptake and have high 
rates of natural transformation. This supports the idea that these organisms are capable 
of exchanging resistance genes with others (Peleg et al., 2008). The toxin producing 
anaerobe, Clostridium difficile is also hospital acquired and found to cause severe 
intestinal infections. This gram-positive spore former can be readily transmitted by 
hospital personnel and equipments (Gifford and Kirkland, 2006). Once ingested, these 
organisms reside in the human gut but their numbers are kept low by normal gut flora. 
If the gut flora are eliminated by antibiotics, these Clostridia colonize the entire gut and 
release toxins which can result in the serious intestinal infection, pseudomembranous 
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colitis. Recently, hypervirulent toxin producing strains have also been recognized 
(Vernaz et al., 2009).    
     The most famous superbug is the gram-positive bacterium, Staphylococcus aureus. It 
is a nasal commensal in 30% of the population and causes common skin infections such 
as impetigo and boils (Enright et al., 2002 and Tenover et al., 2001). In 1959, the 
antibiotic methicillin was discovered to suppress penicillin resistant  S. aureus, but 
within 3 years methicillin-resistant S. aureus (MRSA) had arisen (Barber, 1961; DeLeo 
and Chambers, 2009). The MRSA is a well-known hospital pathogen. More than 10% of 
bloodstream infections in hospitals are due to MRSA and patients with MRSA have 
worse outcomes than those with methicillin-sensitive S. aureus (Selvey et al., 2000). In 
recent years, identification of MRSA in healthy individuals in a community has become 
increasingly common (Delaney et al., 2008; Klevens et al., 2007). Thus, an increase in the 
development of drug resistance among many opportunistic pathogens presents a major 
health and economic concern. 
1.3 Development of Antibiotic Resistance:      
     Bacteria develop antibiotic resistance primarily by: point mutations and horizontal 
gene transfer (HGT). The development of resistance by point mutation occurs only by 
chance i.e., bacteria develop mutations at a rate faster than other organisms, as they 
have shorter generation times and the rapid rate of DNA replication may produce errors 
leading to mutations (Walsh, 2003). Some of these mutations give selective advantage 
for their survival, such as protection against antibiotics in their surroundings. Such 
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resistance mutation can remain in the bacterial population and it can be passed on to 
successive generations through vertical transmission (from parent to offspring) (Walsh, 
2003). For instance, M. tuberculosis developed multidrug resistance exclusively by 
spontaneous mutation. Streptomycin is the antibiotic most commonly used against M. 
tuberculosis but streptomycin resistant strains are creating problems in patients with 
compromised immune system and resulting in high morbidity and mortality rates (Shah 
et al., 2007; Sotgiu et al., 2009; Velayati et al., 2009). Mutations in the ribosomal protein 
S12 or within the 530 loop of 16S rRNA are responsible for streptomycin resistance in M. 
tuberculosis. A single amino acid change from lysine to either arginine or threonine on 
S12 and 16S rRNA is enough for M. tuberculosis to become resistant to streptomycin 
(Finken et al., 1993). Thus, mutation plays an essential role in the development of drug 
resistance in bacteria. However, bacteria can also gain drug resistance by other means 
such as horizontal gene transfer (Figure 1) (Fajardo, et al., 2009; Freifelder, 1987; 
Phornphisutthimas et al., 2007).  
     There are three types of mechanisms involved in horizontal gene transfer (HGT): 1. 
Transformation, 2. Conjugation, and 3. Transduction (Figure 1). Transformation is a 
process by which bacteria take a small amount of cell free DNA from the surroundings 
which is released from other dead bacteria. Conjugation is a process of gene transfer 
that needs direct contact between a donor and a recipient cell. The donor cell carries a 
special type of plasmid or fertility (F) factor which promotes gene transfer. Transduction 
is a process of gene transfer that occurs when viruses carrying bacterial genes infect 
bacteria. These mechanisms are illustrated in Figure 1. The genetic elements that are 
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transferred by HGT can be any of the following: small fragment of bacterial genomic 
DNA, a plasmid, transposon, integron and bacteriophages (Freifelder, 1987; Heuer et al., 
2002). Hence, it is important to analyze the presence of drug resistant bacteria and 
plasmids in biosolids and also for their role in transferring resistance genes to others in 
the bacterial community.  
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Figure 1: Mechanism of horizontal gene transfer (HGT) in bacteria. The three types of 
mechanisms involved in HGT: 1. Transformation (uptake of cell-free DNA), 2. 
Conjugation (bacterial mating), and 3. Transduction (gene transfer by viruses) 
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1.4 Plasmids and Antibiotic Resistance: 
     A plasmid is a circular, autonomously replicating DNA molecule. It may carry genes 
that can be beneficial to their host (e.g., genes which code for drug resistance, virulence 
factors etc.) (Carattoli, 2009). The resistance genes within the plasmids may be 
responsible for inactivation of antibiotics and the mechanisms involved are: 1. drug 
modification, 2. drug degradation, 3. drug efflux and 4. drug target alteration (Figure 2) 
(Walsh, 2003). The drug modification and degradation processes involve specific 
enzymes encoded by the resistance genes carried on plasmids. These enzymes 
recognize and bind to the incoming antibiotic molecules and either cleave or modify 
them chemically to prevent antibiotics from binding to their targets. Another 
mechanism called drug efflux involves efficient transport of antibiotics from the inside 
to the outside of the bacterial cell. In the target alteration mechanism, a specific cellular 
target for a drug is altered through mutation to prevent the drug from binding and 
making them ineffective. These four mechanisms are illustrated in Figure 2. All these 
mechanisms can be regulated by the antibiotic resistance genes present on plasmids 
(Walsh, 2003).  
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Figure 2: Mechanism of antibiotic resistance. The four mechanisms involved in 
antibiotic resistance are: 1. drug inactivation, 2. drug modification, 3. drug efflux, and 4. 
target alteration.  
 
     Again, the resistance (R) plasmids can be a threat to humans and animals because it 
can be transferred laterally among bacteria of different genera by HGT (Figure 1) 
(Couturier et al., 1988). Based on their ability to move between different bacteria, 
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plasmids are categorized into: 1. self-transmissible or conjugative, and 2. 
nonconjugative or mobilizable plasmids (Salyers and Amabile-Cuevas, 1997). 
Conjugative plasmids carry tra genes needed for conjugation and they do not need any 
external support for their gene transfer. By contrast, nonconjugative plasmids lack tra 
gene functions, so they depend on the tra genes of other conjugative plasmids for their 
gene transfer (Freifelder, 1987). For instance, when planktonic bacteria carrying 
plasmids come into contact with a biofilm population composed of recipient cells with 
no plasmids, planktonic bacteria will form biofilms and transfer infectious plasmids to 
the recipient. Plasmids can transfer antibiotic resistance and virulence factors, threofore 
plasmids involved in biofilm formation can produce infecions that are hard to treat 
(Ghigo, 2001). Since, R plasmids play a significant role in gene exchange between 
organisms, it is important to analyze the presence of R plasmids in environmental 
samples such as biosolids.  
1.5 Accumulation of Antibiotics in the Environment: 
     As antibiotics are poorly absorbed in the gut of animals and humans, a large amount 
of them are excreted unchanged in feces and urine (Sarmah et al., 2006). For example, 
40-90% of sulphonamides and tetracyclines are excreted unchanged in feces after 
passage through the gastro-intestinal tract of swines (Winckler and Grafe, 2001). 
Antibiotics are not easily degraded in soils, especially when they are spread onto soils as 
contaminants in sludge (Halling-Sorensen, 1998; Thiele-Bruhn, 2003). They can persist in 
the environment for a long time (2-6 months) and can reach ground water or aquatic 
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sediments through application of liquid manure or sewage sludge as fertilizers (Kuhne et 
al., 2001; Kummerer, 2001; Richardson and Bowron, 1985). In the USA, a nationwide 
survey was conducted regarding the presence of pharmaceuticals in river water 
samples. The data revealed a number of veterinary and human antibiotics in 
concentrations of 0.7% in 27% of 139 river water samples (Kolpin et al., 2002). 
Application of dairy farm manure to a garden soil caused a 70% increase in bacterial 
resistance against ampicillin, penicillin, tetracycline, vancomycin and streptomycin 
(Esiobu et al., 2002). Therefore, application of manure as a fertilizer increases the 
chance of drug resistance among bacterial communities (Sarmah et al., 2006). 
1.6 Production of Biosolids: 
     Biosolids are nutrient-rich organic materials produced during treatment of 
wastewater. Once wastewater from households and industry reach a sewage treatment 
plant, it undergoes several physical, chemical and biological processes to reduce organic 
matter, eliminate heavy metals and disease causing pathogens. First, the raw sewage is 
filtered to remove large solid materials and the liquid undergoes aerobic and anaerobic 
digestion. In the aerobic treatment process, wastewater is mechanically agitated with 
the supply of air and the temperature is maintained at 15-20°C for 40 days to activate 
aerobic microorganisms which reduce biological oxygen demand and stabilize 
suspended solids in the wastewater (U.S. EPA, 1994). This is followed by an anaerobic 
digestion process in which the temperature is maintained at 20-55°C for 40 days in the 
absence of oxygen to transform organic materials in the sludge to gases such as 
methane and carbon dioxide. By the end of aerobic and anaerobic digestion processes, 
14 
 
there will be a reduction in the quantity of solids and pathogenic organisms. The sludge 
is then air dried for 2 months and lime is added to raise the pH and eliminate odors (U.S. 
EPA, 1994). Later, composting materials like saw dust and yard waste are added to the 
sludge and the final product is called biosolids. The processes involved in the production 
of biosolids are illustrated in Figure 3.  
     The biosolids are recycled and applied as fertilizer to promote plant growth as they 
are rich in nutrients like nitrogen, phosphorous, potassium and trace amounts of 
calcium, copper, iron, magnesium, manganese, sulfur and zinc (U.S. EPA, 2001). In the 
United States, approximately 5.6 million dry tons of biosolids are generated annually 
and 60% of them are used as fertilizer whereas the rest is incinerated or dumped in 
landfills (National Research Council, 2002). Biosolids are used as a fertilizer in public 
parks, agricultural lands, forest lands, reclamation sites, golf courses, road sides, plant 
nurseries, lawns, and home gardens (U.S. EPA, 1994).  
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Figure 3: Production of biosolids. The biosolids undergo several processes before they are 
applied to lands. These include 1. aerobic and anaerobic digestion, 2. lime stabilization, and 3. 
composting. 
Raw sewage 
Filtered to remove solid material 
Liquid is subjected to aerobic and anaerobic 
digestion 
Liquid is chlorinated 
Released into 
environment 
Suspended solid material is 
removed 
Stabilized using lime and 
composting materials: wood chips, 
yard waste 
Biosolids 
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1.7 Regulations for Biosolids: 
     As biosolids are being applied to lands as a fertilizer, it must meet some regulations 
and quality standards before its application. The U.S Environmental Protection Agency 
(EPA) established a set criterion for the concentration of heavy metals and pathogens 
(e.g., bacteria, viruses and parasites) permitted in biosolids for the safety of humans and 
animals. The EPA classified biosolids into two types based on their pathogen content - 
class ‘A’ and class ‘B’ (EPA, 1994). The class ‘A’ type undergoes some additional steps 
like heat drying, pasteurization, β-ray irradiation and gamma ray irradiation to further 
reduce the number of pathogens - but those treatment methods vary among treatment 
plants. In general, class ‘A’ is tested for the following indicator organisms and 
pathogens: Salmonella, fecal coliforms, enteric viruses and helminthes ova, whereas 
class ‘B’ is tested only for fecal coliforms such as E.coli, Citrobacter, Enterobacter and 
Klebsiella. The number of pathogens and their concentration allowed in class ‘A’ and ‘B’ 
are shown in Table 2. The class ‘A’ type is recommended by the U.S EPA for application 
to home gardens and public parks, and the class ‘B’ for crop lands and forestry. The 
potential risks associated with application of biosolids are discussed in the next section.   
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Table 2: The U.S EPA - Pathogen Concentration Limits  
Pathogen / indicator and class Standard concentration limits  
(dry wt.) 
Class A 
Salmonella 
Fecal coliforms 
Enteric viruses 
Viable helminthes ova 
 
< 3 MPN/4 g total solids 
< 1000 MPN/g total solids 
< 1 PFU/4g total solids 
< 1 PFU/4g total solids 
Class B 
Fecal coliform density 
 
< 2 million MPN/g total solids 
Note: MPN – most probable numbers; PFU – plaque forming unit. Source: The U.S. EPA, 
2001 
 
1.8 Potential Hazards of Biosolids: 
      Although the EPA regulates biosolids use, there are risks associated with such 
application. Studies show that biosolids are unsafe for land application due to: 1. 
dispersion of bioaerosols from application sites (Baerisch et al., 2007; Pillai et al., 1996), 
2. contamination of food and groundwater (Edmonds, 1976; Sidhu and Toze, 2009; 
Tamminga et al., 1978; Wei et al., 2010), and 3. prevalence of viruses and resistant 
strains of bacteria (Binh et al., 2008; Ewert and Paynter, 1980; Ward et al., 1981; Wong 
et al., 2010). It has been shown that gene transfer occurs between different strains of 
Enterococcus faecalis under natural conditions in wastewater treatment plants 
(Marcinek et al., 1998). Several pharmaceutical compounds (ibuprofen, acetaminophen, 
gemfibrozil), and antibiotics (ciprofloxacin, ofloxacin, azithromycin) persist in biosolids 
despite of all the treatment processes (Radjenovic et al., 2009; Spongberg and Witter, 
2008). Presence of antibiotics in biosolids put selective pressure on bacteria and select 
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for drug resistant determinants. These resistant organisms can act as a reservoir for 
drug resistance plasmids (Binh et al., 2008; Viau and Peccia, 2009). In addition, human 
and bacterial viruses present in sewage can be maintained because they are more 
resistant to ammonia and heat treatments (Burge et al., 1983; Lund et al., 1996; Viau 
and Peccia, 2009). These studies support an idea that resistant bacteria transfer 
resistance genes to other organisms through vertical and horizontal transmission. 
Therefore, it is necessary to examine these possibilities in biosolids before their land 
application.   
1.9 Significance of Bacteria in Enterobacteriaceae Family: 
     The Enterobacteriaceae is a large family of gram negative bacteria and some 
members are part of a normal gut flora of humans and animals. However, members of 
this family such as E.coli, Salmonella and Proteus are known pathogens while others like 
Enterobacter, Klebsiella and Serratia cause secondary wound infections, respiratory and 
urinary tract infections (Table 3). As these members are found in human and animal 
intestine, they are present in sewage in large quantity and in biosolids in spite of the 
wastewater treatment processes. It has been shown that members of 
Enterobacteriaceae are resistant to multiple drugs and infections caused by these 
resistant organisms are hard to treat (Paterson, 2006; Salyers and Amabile-Cuevas, 
1997). Studies show that members of this family (e.g., Salmonella and other fecal 
coliforms) are able to regrow and colonize after biosolids are applied to lands (Zaleski et 
al., 2005). As members of the Enterobacteriaceae family are enteric pathogens, it is 
crucial to study these organisms in biosolids. 
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Table 3: Clinical syndromes caused by members of the Enterobacteriaceae 
family 
Bacteria Habitat / Source 
 
Disease 
 
Citrobacter spp. Soil, water and wastewater Urinary tract infection, infant meningitis and sepsis 
Enterobacter spp. Soil, water and human intestine 
Urinary and respiratory tract 
infections 
E.coli 0157:H7 Human intestine Diarrhea and severe kidney failure 
Klebsiella pneumonia 
Nosocomial; Spread by 
hospital personnel and 
equipment 
Pneumonia, diarrhea 
bacteremia and sepsis 
Proteus spp. Soil, water, wastewater and human intestine 
Wound infections, 
pneumonia and septicemia 
Serratia marcescens 
Nosocomial; Spread by 
hospital personnel and 
equipment 
Urinary tract, wound 
infection and septicemia 
Salmonella spp. 
Shigella spp. 
Contaminated food and 
water, animal and human 
intestine 
Diarrhea, enteric fever, 
septicemia and reactive 
arthritis 
 
1.10 Plasmid Extraction and Transformation: 
    The presence of resistance genes on plasmids can be examined by transformation. For 
such an analysis, plasmids can be extracted from antibiotic resistant bacteria and these 
cell-free plasmids can be mixed with an antibiotic sensitive laboratory strains of E. coli. 
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Through the transformation process, bacteria take a small amount of cell free DNA from 
their surroundings and keep them in their cytoplasm as a plasmid or incorporate them 
into their chromosome (Andersson and Hughes, 2010). The bacteria that are susceptible 
to transformation in both natural and artificial environments are called competent cells. 
In a lab, competence can be achieved by treating the cells with chemicals (e.g., CaCl2) 
and using high voltage electric pulse (electroporation) (Froger and Hall, 2007; Hill et al., 
1992). The process of transformation is illustrated in Figure 4. Using transformation 
process, drug resistance genes (R) present on plasmids can be identified.  
 
Figure 4: Mechanism of transformation in bacteria. Transformation is a process by which 
bacteria take a small amount of cell free DNA from their surroundings. Once the DNA enters a 
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cell, it will be maintained stably as a plasmid or may be integrated into their chromosome. In 
either case, the new DNA is passed on to successive generations.  
 
1.11 Phage Sensitivity Assay:     
     To determine whether plasmids are of the conjugative or non-conjugative type, a 
phage sensitivity assay can be used. Viruses can replicate only in specific host. Based on 
the host they live in, they are classified into three types: 1. viruses that infect bacteria 
are called bacteriophages or phages, 2. viruses that infect plants  are referred as plant 
viruses, and 3. viruses that infect animals and humans. For the identification of 
conjugative and non-conjugative plasmids, bacteriophages or phages can be used.  
     Bacteriophages basically consist of a nucleic acid molecule (DNA or RNA) surrounded 
by a protein coat called capsid (Lipton and Weissbach, 1969). After infection, phages use 
the bacterial ribosomes, protein-synthesizing factors and energy-generating systems for 
their replication, hence phages can only multiply in metabolizing bacterial cells (Sobsey 
et al., 1995). Phages that infect E.coli bacteria are called coliphages. Attachment or 
receptor sites for coliphages are located on different parts of bacteria. Based on the 
receptor sites, coliphages are classified into two types: somatic and male-specific (F+) 
coliphages. Some receptors for coliphages are located on the bacterial cell wall and are 
present all the time. These receptors are recognized by phages known as somatic 
phages. This implies that somatic phages can infect host bacteria at any time, and these 
phages will attach to even dead bacteria. Some examples of somatic phages are T4, T5, 
λ and P22 phages (Furuse et al., 1981; Long et al., 2005).  Receptor sites for other 
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coliphages are located on the fertility (sex) fimbriae of host bacteria. These fimbriae are 
produced only by bacteria carrying F-factor in the log growth phase under optimal 
conditions. Coliphages which utilize these receptor sites are known as male-specific (F+) 
phages. Some examples of male-specific phages are Qβ, M13, MS2 and f1 (Furuse et al., 
1981; Long et al., 2005; Sobsey et al., 1995).  
     Bacteriophages share many fundamental properties with human viruses. For 
example, F+ RNA coliphages and polioviruses, both have an icosahedral capsid with a 
diameter of about 25nm and a single stranded (ss) RNA genome (Havelaar, 1993; Hsu et 
al., 1995). Both F+ RNA coliphages and enteroviruses are excreted by humans and 
animals. Coliphages are excreted at all times by many humans and warm-blooded 
animals, whereas enteric viruses of human health concern are excreted only by humans 
during infection which may last for few days to few weeks (Sobsey et al., 1995). For 
these reasons, coliphages are valuable models for the study of human and animal 
enteric viruses (Gantzer et al., 1998). In addition, coliphages are easily and rapidly 
cultivated in labs which makes them good indicators for the presence of enteric viruses 
in water, food, shellfish, and wastewater (Furuse, 1981; Sobsey et al., 1995). 
     To identify conjugative plasmids present in biosolids, Qβ phages can be used. Qβ 
phage belongs to the family Leviviridae. The phage genome is surrounded by a cubic or 
icosahedral protein capsid without a tail.  Qβ has a single-stranded RNA genome of 
4,217 bases that encodes four genes for A2, A1, coat protein and the RNA replicase β 
subunit (Duin, 1988; Klovins et al., 1998). The host for Qβ is male specific (F+) E.coli cells. 
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Phage infection starts by attachment of Qβ to the E.coli F pilus followed by the release 
of phage RNA into the host cell (Figure 5). After the release, phage directs the host 
machinery to make copies of the phage RNA and to form a coat protein (Takeshita et al., 
2012; Tsukada et al., 2009). The phage heads are then assembled with the newly 
synthesized RNA followed by the release of phages by rupture or lysis of the bacterial 
cell within as little as 1 hour after infection (Figure 5). The newly released phages go and 
attach to other bacterial cells carrying F-factor and the process continues. These phages 
typically produce clear plaques on a lawn of susceptible host bacteria (Davis et al., 1990; 
Takeshita et al., 2012; Tsukada et al., 2009). Thus, this technique can be used to 
distinguish between cells carrying conjugative and non-conjugative plasmids (Miller, 
1972). 
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Figure 5: Infection of RNA phage and cell lysis. RNA phages such as Qβ attaches to the host 
bacteria through F pili and inserts their genome into the host. The phage RNA then uses the host 
machinery for making copies of their genome and protein coat. The newly synthesized RNAs are 
then packed into empty phage heads and the fully packed heads or virions are released by lysing 
the host cell. The released phages go and attach to other bacterial cells and the process 
continues.  
 
1.12 Mechanism of Conjugation: 
     Once again, the plasmids involved in HGT are of two types: (i) self-transmissible or 
conjugative, and (ii) nonconjugative or mobilizable plasmids (Salyers and Amabile-
Cuevas, 1997). The self-transmissible plasmids carry necessary genes (tra or transfer) to 
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promote their gene transfer. However, the mobilizable plasmids lack transfer function 
(tra genes) but contain an ori site (a specific sequence that allows for their transfer), so 
in the presence of conjugative plasmids they are able to transfer their genes to a 
recipient (Freifelder, 1987).  
     The mobility of plasmids can be examined by the conjugation process which requires 
a physical contact contact between donor and recipient cells. The donor cell is referred 
to as 𝐹+ because it carries a conjugative plasmid for conjugation, whereas the recipient 
cell lacking a conjugative plasmid is called the 𝐹−cell (Moat et al., 2002). The F plasmid 
encodes a sex pilus, a protein appendage which recognizes and binds to receptors on a 
recipient bacterial cell wall. The cell membrane of donor and recipient fuses together 
and creates a passage between bacteria for DNA transfer. Then, a plasmid encoded 
endonuclease cleaves the plasmid at a specific site called the origin of transfer (ori T). 
After that, the 5' end of a single stranded DNA starting from the ori T enters a recipient 
𝐹−cell (Phornphisutthimas et al., 2007). Later, complementary strands are synthesized 
in both (𝐹+and 𝐹−) bacteria by a rolling circle mechanism. It has been shown when 
𝐹+ and 𝐹−cells are mixed together that eventually all the cells will become 𝐹+ (Moat et 
al., 2002). The processes involved in conjugation are depicted in Figure 6. Hence, 
conjugative plasmids can be identified by conjugative transfer or by their susceptibility 
to male-specific coliphages such as Qβ and M13 phages (see section 1.11). If the 
plasmids are non-conjugative, they can be identified by a tripartite mating process 
which is described below.  
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     Tripartite mating is similar to conjugation and can be used to identify non-conjugative 
or mobilizable plasmids. As mentioned earlier, non-conjugative plasmids are not able to 
make direct gene transfer because they lack transfer function (tra genes) but these 
plasmids carry an ori site (a specific sequence that allows for their transfer), so in the 
presence of conjugative plasmids they are able to transfer their genes to a recipient cell 
(Freifelder, 1987). In tripartite mating, there will be three strains involved: donor, helper 
and recipient. The helper strain carry tra genes for transfer function, so it will help the 
donor to transfer the plasmid to the recipient cell. It has been shown that in the 
presence of bacteria carrying tra genes, non-conjugative plasmids are able to transfer 
their genes to recipient bacteria (Droge et al., 2000; Schluter et al., 2007). Thus, non-
conjugative plasmids can be identified by the tripartite mating process.  
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Figure 6: Mechanism of conjugation in bacteria. The donor cell contains an F plasmid which 
encodes an F pilus for conjugation. The F pilus is a protein appendage which recognizes and 
binds to receptors on a recipient cell wall, and then the cell wall fuses together and creates a 
passage between the two bacteria for plasmid DNA transfer.  
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1.13 Objectives: 
     The goal of this study was to (1) examine the presence of drug resistant bacteria in 
Cheney biosolids, (2) to screen them for the presence of resistance (R) plasmids, (3) to 
verify the location of resistance genes on R-plasmids, and (4) to identify whether the R-
plasmids are of a conjugative or a non-conjugative type.  
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2. Materials and Methods: 
2.1 Bacterial Growth Media: 
     For growth and isolation of bacteria both liquid and solid media were used. The media used 
were: MacConkey agar and Tryptic soy agar (TSA) (Difco, Detriot, MI), Luria-Bertani (LB) agar and 
LB broth (Mo-bio, Carlsburg, CA). MacConkey agar was prepared by adding 50g of powder per 
liter of deionized water and boiled to dissolve completely. TSA was prepared by dissolving 40 g 
of powder in a liter of deionized water. LB broth was prepared by adding 20g of powder per liter 
of deionized water. LB agar was prepared by mixing 35 g of powder in a liter of deionized water. 
All media were sterilized by autoclaving at 121°C and 15 psi for 15 minutes.  
2.2 Preparation of Antibiotic Stock Solutions: 
     Antibiotics added to the growth media (either broth and agar plates) were made from the 
following powdered antibiotics: Ampicillin sodium salt, Tetracycline hydrochloride, Kanamycin, 
Nalidixic acid, Streptomycin sulfate salt, Chloramphenicol, Rifampin. All antibiotics were 
purchased from Sigma-Aldrich, St. Louis, MO. The antibiotic stock solutions were prepared as 
recommended by Sambrook et al., 1989.  
     All antibiotic solutions were prepared with sterile deionized water in 1.5 ml sterile Eppendorf 
tubes. Ampicillin stock solution (100 mg / ml) was prepared by dissolving 100 mg of ampicillin 
sodium salt in 1 ml of deionized water in a 1.5 ml Eppendorf tube. Tetracycline stock solution 
(15 mg / ml) was prepared by adding 15 mg of Tetracycline hydrochloride to 1 ml of 50% 
Ethanol. Kanamycin solution (50 mg / ml) was prepared by dissolving 50 mg of Kanamycin in 1 
ml of deionized water. Nalidixic acid solution (30 mg / ml) was prepared by dissolving 30 mg of 
Nalidixic acid in 1 ml of 1M NaOH. Streptomycin solution (100 mg / ml) was prepared by mixing 
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100 mg of Streptomycin sulfate salt in 1 ml of deionized water. Chloramphenicol stock solution 
(20 mg / ml) was prepared by adding 20 mg of Chloramphenicol to 1 ml of 95% Ethanol. 
Rifampin solution (100 mg / ml) was prepared by mixing 100 mg of Rifampin in 1 ml of Methanol 
and dissolved by adding 3 drops of 10N NaOH.  
     All antibiotics were dissolved by vortexing and the mixture was filter sterilized using a 0.2 µm 
syringe filter. The filtrate was collected in 1.5 ml sterile Eppendorf tubes and stored at -20°C 
until use. From the antibiotic stock solution, appropriate amount was mixed with LB broth and 
agar before use. The final concentration of antibiotics used were: ampicillin (100 µg / ml), 
tetracycline (15 µg / ml), streptomycin (100 µg / ml), kanamycin (50 µg / ml), rifampin (100 µg / 
ml), nalidixic acid (30 µg / ml) and chloramphenicol (20 µg / ml). These final concentrations were 
determined based on a recommendation by Sambrook et al. (1989). 
2.3 Preparation of Buffer and Solutions: 
     Dulbecco’s phosphate buffered saline (PBS) was prepared by mixing the following: 13.7 mM 
NaCl, 0.27 mM KCl, 1 mM Na2HPO4 and 0.2 mM KH2PO4 in 800 ml of deionized water. The pH 
was adjusted to 7.4 with HCl and the final volume was adjusted to 1 liter with additional water. 
Saline solution was prepared by dissolving 0.85 g of NaCl in 100 ml of deionized water. The PBS 
and Saline were sterilized by autoclaving at 121°C and 15 psi for 15 minutes before use. Both 
PBS buffer and saline solution (0.85 %) were used for making serial dilutions of biosolid samples. 
The gel electrophoresis buffer, Tris-Acetate EDTA (TAE) was prepared by mixing 0.04 M Tris-
acetate and 0.001 M Ethylenediaminetetraacetic acid (EDTA), disodium salt in 800 ml of 
deionized water. The pH was adjusted to 8.0 with acetic acid and the final volume was adjusted 
to 1 liter with additional water. The TAE buffer was used for running an agarose gel 
electrophoresis.    
31 
 
 
2.4 Collection of Biosolids and Inoculation onto Selective Media: 
     Biosolid samples were collected from a wastewater treatment facility, Cheney, WA. Roughly 
500 g of biosolids were collected in sterile glass bottles. They were placed on ice and 
transported to lab and stored in a 4°C cold room until use. From that, 10 g of biosolids were 
suspended in 90 ml of PBS and placed on a rotary shaker for 3 hours. The liquid was collected 
and serial dilutions (10-2 to 10-7) were made. The diluted sample (100 µl) was spread on 
MacConkey agar and incubated at 37°C for 24-36 hours. Single isolated colonies were picked 
randomly with sterile toothpicks and streaked on antibiotic plates, and the plates were 
incubated at 37°C for 36-48 hours. Resistant bacterial strains were once again tested on the 
antibiotic plates using the same procedure to ensure that the isolates were truly resistant to the 
antibiotics used.  
2.5 Bacterial Strains Used: 
     The bacterial strains and phages used in this study were: Escherichia coli MM294, E. coli 
DH5α, E. coli XK1502, E. coli MC4100 and phages Qβ and M13. The source and genotype for 
these organisms are shown in Table 4a and 4b. 
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Table 4a: 
Control 
Bacteria 
Strain 
Designation 
Genotype Source 
Escherichia coli MM294 F -, glnV44(AS), λ-, rfbC1, endA1, spoT1, 
thiE1, hsdR17, creC510 
Coli Genetic Stock Center 
(CGSC) #:6315 
Escherichia coli DH5α F -, φ80lacZΔM15 Δ(lacZYA-argF)U169, 
recA1 endA1, hsdR17(rk-, mk+), 
phoAsupE44 thi-1, gyrA96, relA1 λ- 
Biology department 
collection 
Escherichia coli MM294 
transformed 
with pGLO 
F -, glnV44(AS), λ-, rfbC1, endA1, spoT1, 
thiE1, hsdR17, creC510 
Biology department 
collection 
Escherichia coli MC4100 F -, [araD139]B/r, Δ(argF-lac)169, λ-, e14-, 
flhD5301, Δ(fruK-yeiR)725(fruA25), relA1, 
rpsL150(strR), rbsR22, Δ(fimB-
fimE)632(::IS1), deoC1 
Dr. Steve Moseley, 
Microbiology 
Department, UW 
Escherichia coli XK1502 F', lacU169, traD8, nalA Dr. Steve Moseley, 
Microbiology 
Department, UW 
 
 
Table 4b: 
Control Phage Strain Designation Source 
 
RNA Phage 
 
Qβ 
Dr. Steve Moseley, Microbiology 
Department, UW 
Single-stranded (ss) DNA phage M13 From our collection 
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2.6 Long Term Storage of Bacterial Isolates: 
     Resistant bacterial isolates were stored at -80°C in LB broth containing 15% (v/v) glycerol 
(Sigma Aldrich, St. Louis, MO). Bacterial isolates were streaked on LB plates containing 
antibiotics and incubated at 37°C for 24 hours to get individual colonies. A single isolated colony 
was picked and transferred to a 5ml LB broth containing antibiotics and placed on a 37°C shaker 
for 18 hours. Then, 0.7 ml of cell suspension was transferred to sterile 1.2 ml Cryovial (Midsci™, 
St. Louis, MO) and mixed with 0.3 ml of sterile 15% (v/v) glycerol. Samples were stored at -20°C 
for 48 hours and then moved to -80°C for long-term storage.   
2.7 Plasmid DNA Extraction: 
     Plasmid DNA was extracted from resistant bacteria using the following kits: GeneJETTM 
Plasmid Miniprep Kit (Fermentas Life Sciences, Burlington, Ontario) and ZyppyTM Plasmid 
Miniprep Kit (Zymo Research, Irvine, CA). Plasmid DNA was extracted from resistant bacteria 
and their size and concentration were determined using 0.7% (w/v) agarose gel electrophoresis.  
     As per the manufacturer’s protocol, an isolated colony was picked from an antibiotic plate 
and transferred to a 5 ml LB broth containing antibiotics and placed in a 37°C shaker for 16-18 
hours. Then, 3 ml of cell suspension was transferred to two 1.5 ml sterile Eppendorf tubes and 
centrifuged at 10,000 X G for 4 minutes at room temperature. The supernatant was discarded 
and the cells were suspended with SDS/alkaline lysis buffer (supplied in kit) to release plasmid 
and genomic DNA. The resulting lysate was neutralized using neutralization buffer from the kit. 
Cell debris, SDS precipitate and the genomic DNA trapped in them were pelleted by 
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centrifugation and the supernatant containing the plasmid DNA was loaded onto the spin 
column membrane for further purification. The adsorbed DNA was washed to remove 
contaminants using wash buffer supplied in the kit. Finally, the plasmid DNA was eluted with 
elution buffer (from kit) and the DNA was stored at -20°C until use.  
2.8 Agarose Gel Electrophoresis: 
     The agarose gel electrophoresis was used for the separation and visualization of plasmid DNA 
and also to determine the size and concentration of the DNA. The materials used for that 
purpose were: agarose (Invitrogen, Eugene, OR), TAE buffer, an electrophoresis chamber (Owl 
model B1A class II, Owl Separation Systems, Portsmouth, NH), 6X loading dye (New England 
Biolabs, Ipswich, MA) containing 5X SYBR gold (Invitrogen, Carlsbad, CA), Supercoiled DNA 
ladder  (2-10 kb)(Cat#N04725, New England Biolabs, Ipswich, MA), 1 kb DNA ladder (0.5-
10kb)(Cat#N3232S, New England Biolabs, Ipswich, MA), an Ultraviolet Transilluminator 
(Ultraviolet Products, Upland, CA) and Kodak EDAS 290 (Kodak, Rochester, NY) imaging system.  
     A 0.7% (w/v) gel was prepared by dissolving 0.35 g of agarose (Invitrogen, Eugene, OR) in 50 
ml of TAE buffer and poured into an electrophoresis chamber (Owl model B1A class II, Owl 
Separation Systems, Portsmouth, NH). Samples (3 μl) were mixed with 1 μl of 6X loading dye 
(New England Biolabs, Ipswich, MA) containing 5X SYBR gold (Invitrogen, Carlsbad, CA) and the 
total mixture (4 μl) loaded into wells and allowed to run at 58-volt for 3 hours. A (2-10 kb) 
Supercoiled DNA ladder (Cat#N04725 New England Biolabs, Ipswich, MA) was used to determine 
the size and concentration of plasmid DNA. The DNA within the gel matrix was visualized with an 
Ultraviolet Transilluminator (Ultraviolet Products, Upland, CA) and photographed with a Kodak 
EDAS 290 (Kodak, Rochester, NY) imaging system. The size and concentration of the sample DNA 
were measured by comparing visually the fluoresecence of sample DNA band(s) with the 
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standard DNA ladder. Based on the size of sample DNA band(s) their corresponding 
concentrations were determined using the standard DNA concentration chart provided by the 
supplier.  
2.9 Identification of Bacteria: 
     The bacterial isolates were identified using API-20E system and oxidase test. The materials 
used were: 0.85% saline solution, TSA plates, mineral oil, sterile tooth picks, sterile filter papers 
(Whatman No.1), API strips (BioMerieux, Durham, NC) and Oxidase reagent (Becton, Dickson 
and Company, Sparks, MD). Bacteria were grown on TSA plates at 37°C for 18-24 hours. A single 
well-isolated colony was picked and suspended in 0.85% saline solution and mixed thoroughly. 
Using a sterile pipette, bacterial suspension was added into the cupules of API strips and then 
mineral oil was added in recommended cupules and the strips were incubated at 37°C for 24-36 
hours. Later, other reagents (BioMerieux supplies) were added and the color change was 
recorded as (+) and (–) signs. Based on the (+/-) score, an organism was identified using the 
Analytical Profile Index (BioMerieux, Durham, NC, 1999). For oxidase test, few drops of Oxidase 
test reagent (Becton, Dickson and Company, Sparks, MD) were added to a strip of Whatman 
filter paper. A single isolated colony was streaked on top of the reagent using a sterile toothpick 
and the color change from white to dark blue is considered as positive and no color change was 
considered as negative for the test.  
2.10 Preparation of Competent Cells: 
     The competent cells were prepared as described in the MicroPulser lab manual (Bio-Rad, 
Hercules, CA). The E. coli MM294 was grown in a 5 ml LB broth on a 37°C rotary shaker for 18-24 
hours. Then, 500 ml of fresh LB broth was inoculated with 5 ml of overnight E. coli culture and 
36 
 
grown on a 37°C shaker till the culture had reached the cell density of 0.3-0.5 at A550 using the 
SHIMADZU UV-1201 spectrophotometer (Columbia, MD). The culture was chilled on ice for 30 
minutes and transferred to ice-cold centrifuge tubes and spun at 4000 X G for 15 minutes at 4°C 
using a Sorvall RC5B refrigerated centrifuge (Sorvall, Newtown, CT). The supernatant was 
discarded and the bacterial pellet was suspended with 500 ml of ice-cold MilliQ® water and 
spun at 4000 X G for 15 minutes at 4°C. This step was repeated twice with 250 ml ice-cold MilliQ® water and centrifuged in the same condition. The bacterial pellet was suspended in 20 
ml ice-cold 10% (v/v) glycerol and spun at the same condition. Finally, the cell pellet was 
suspended in 2 ml of ice-cold 10% (v/v) glycerol and divided into small aliquots (50 µl) in 0.5 ml 
sterile Eppendorf tubes and stored at -80°C until needed. 
2.11 Transformation: 
     Electroporation was carried out using a MicroPulser (Bio-Rad, Hercules, CA).  The following 
items were used for that purpose: Super Optimal Broth (SOB) containing 10mM glucose, 
electroporation cuvette (0.2 cm gap), LB plates with appropriate antibiotics and a 37°C shaker.  
     The electro-competent cells were retrieved from a freezer and thawed on ice. Cell suspension 
(50 µl) was mixed with either 0.2 µg of pBR322 (positive control) or 0.3 µg of plasmid DNA 
extracted from the isolates. The mixture of cells and DNA were incubated on ice for 2 minutes 
and transferred to a cold electroporation cuvette. This mixture was subjected to one 2.5 kV 
pulse for 5 milli sec using a Bio-Rad MicroPulser (provided by Dr. Andrea Castillo, EWU Biology 
Dept). After a pulse, 1 ml of SOB medium was added to the cuvette and the entire content was 
transferred to a 5 ml test tube and incubated on a 37°C rotary shaker for 2 hours. Then, 100 µl 
of the cell suspension was spread on antibiotic plates and incubated at 37°C for 36-48 hours. 
The bacterial colonies or transformants formed on these antibiotic plates were tested again on 
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the same antibiotic to confirm their drug resistance. Later, plasmids were extracted from the 
transformants using the same procedure as mentioned in the section ‘plasmid DNA extraction’. 
The presence of plasmids and their size and concentration were determined on an agarose gel 
following the same procedure. Plasmids extracted from the transformants were compared with 
the original plasmids used for transformation on an agarose gel to verify similarities between 
these two plasmids.            
2.12 Restriction Digestion: 
     Restriction digestion was performed with the plasmids to confirm their size(s) after linearizing 
them. Plasmid DNA extracted from the transformants was digested with the restriction enzyme 
EcoRI (#FD0274, Fermentas, Glen Burnie, MD). The materials used were: sterile MilliQ® water, 
10X FastDigest buffer (10mM potassium phosphate, 300mM Nacl, 1mM EDTA, 1mM DTT, 
0.2mg/ml BSA, 0.15% Triton X-100 and 50% (v/v) glycerol), sterile 0.5 ml sterile Eppendorf tubes, 
1 kb DNA ladder (N3232S, New England Biolabs, Ipswich, MA) and a 37°C heat block.  
     The reaction mixture (20 µl) was prepared by mixing 15 µl of sterile MilliQ® water, 2 µl of 
10X FastDigest buffer, 1 µg of plasmid DNA and 10 units of EcoRI FastDigest enzyme in 0.5 ml 
sterile Eppendorf tubes. The mixture was spun at 3000 X G for a minute and incubated in a 37°C 
heat block for 3 hours. The digested DNA or 1kb DNA ladder were then mixed with 3 µl of 6X 
SYBR gold containing dye and loaded on a 0.7% (w/v) agarose gel and electrophorized.     
2.13 Assay of Phage Sensitivity: 
    Phage sensitivity assay was performed to determine the presence of conjugative plasmid in 
the isolates. The materials used were Qβ and M13 phages, Ecoli MC4100 and XK1502, 15 ml 
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centrifuge tubes, LB broth, LB plates and chloroform (Sigma Aldrich, St. Louis, MO). The 
procedure for phage sensitivity was followed as suggested by Miller (1972). 
     The Qβ and M13 phage lysate was prepared as follows: E. coli XK1502 were grown in a 5 ml 
LB broth on a 37 °C rotary shaker for 18-24 hours. The overnight culture was diluted (1:100) 
with 5ml of fresh LB broth and allowed to grow for 3 hours on a 37°C rotary shaker. The Qβ and 
M13 phages were added to the bacterial cell suspension in two separate tubes in a ratio 1:10 
and incubated in a 37°C water bath overnight. Three drops of chloroform were added to the cell 
suspension and centrifuged at 5000 X G for 10 minutes and the supernatant was carefully 
removed and stored at 4°C until use. The clear supernatant containing phages (phage lysate) 
was further used in phage sensitivity assay. The test isolates or E.coli XK1502 (positive control) 
or E.coli MC4100 (negative control) were grown to exponential phase and 100µl was plated on 
LB agar and let it dry for an hour. Then, 5µl of phage lysate was spotted on the LB plate 
containing test bacteria or positive control E.coli XK1502 or negative control E.coli MC4100 and 
the plates were incubated at 37 °C for 24 hours. The visible plaques formed on plates indicate 
the presence of conjugative plasmid in bacteria.  
2.14 Tripartite Mating: 
     Tripartite mating process was used to identify non-conjugative but mobilizable plasmids. The 
materials used were: LB broth, LB plates containing antibiotics, control E.coli strains MC4100 
and XK1502, a 37°C shaker. The procedure for tripartite mating was followed as per Miller 
(1972). 
     The tripartite mating process involve three different strains: a donor, a helper and a recipient. 
The donor is the strain isolated from biosolids, helper is the strain of E.coli XK1502 and the 
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recipient is the E.coli MC4100 strain. All the three strains were streaked on suitable antibiotic 
plates to get isolated colonies and incubated at 37°C for 24 hours. A single well-isolated colony 
from each plate was picked and transferred to a 5 ml LB broth and incubated at 37°C for 18-24 
hours. The overnight culture was diluted with 5 ml of fresh LB broth in the ratio 1:40 for donor 
and helper, and 1:20 for recipient and allowed to grow for 3 hours on a 37°C rotary shaker. All 
the antibiotic plates were divided into four sections: 1. Donor (biosolid isolate), 2. Helper (E.coli 
XK1502), 3. Recipient (E.coli MC4100), and 4. Donor + Helper + Recipient. The recipient culture 
(5 µl) was first spotted on appropriate sections and let it dry for 30 minutes. The donor (5 µl) 
was then spotted directly on top of the recipient and let them dry for another 30 minutes. 
Finally, the helper (5 µl) was spotted on top of the recipient and donor spots and allowed to 
completely dry for 30 more minutes, and the plates were incubated at 37°C for 24 hours. The 
transconjugants or bacterial colonies formed on the antibiotic plates in a sector in which all 
three types were mixed together were then evaluated. Conjugation (bi-partite mating) was also 
performed simultanoeusly at the same time of tripartite mating to check whether the biosolid 
isolate carried conjugative plasmid. Conjugation is similar to tripartite mating except there are 
only two strains involved. The antibiotic plates were divided into three sections: 1. Donor 
(biosolid isolate), 2. Recipient (E.coli MC4100) and 3. Donor + Recipient. The diluted fresh 
cultures of donor and recipient as used in tripartite mating were used in this assay. The recipient 
culture (5 µl) was first spotted on appropriate sections and let it dry for 30 minutes. The donor 
(5 µl) was then spotted directly on top of the recipient and let it dry for another 30 minutes and 
the plates were incubated at 37°C for 24 hours. The transconjugants or bacterial colonies 
formed on the antibiotic plates were then evaluated.  
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3. Results and Discussion: 
3.1 Collection of Biosolids and Isolation of Resistant Bacteria: 
     Wastewater serves as a reservoir of bacteria and viruses that may contribute to the 
selection and transfer of antibiotic resistance genes to other bacteria (Binh et al., 2008; 
Lund et al., 1996). Biosolids are the final product of the waste water treatment process, 
and they are used as fertilizer to promote plant growth all over the United States. They 
are used in public parks, agricultural lands and home gardens (U.S. EPA, 1994). People 
can be directly or indirectly affected by such application. For example, bioaerosols or 
microbes can be dispersed through wind, and people can inhale these organisms and 
get infected (Baerisch et al., 2007). Pathogens can enter the human food chain by 
consuming food crops and vegetables grown on biosolid applied lands (Tamminga et al., 
1978; Wei et al., 2010). Farm animals grazing on biosolid applied lands also contribute 
to the spread of pathogens to humans who consume meat products. It has been shown 
that addition of organic wastes to soil in the form of biosolids increases the growth and 
survival efficiency of E.coli and others (Unc et al., 2006). Moreover, several studies 
reported the presence of drug resistant bacteria and viruses in biosolid samples (Binh et 
al., 2008; Wong et al., 2010). To my knowledge, Cheney biosolids are tested primarily 
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for the reduction of Salmonella and fecal coliforms such as E.coli, Citrobacter, 
Enterobacter and Klebsiella. It is not clear whether these biosolids are tested for other 
pathogens like drug resistant bacteria and viruses. In this study, we investigated the 
presence of drug resistant bacteria and their role in the transfer of drug resistance 
genes to other bacteria.      
     Biosolids were collected in June, 2012 from the wastewater facility, Cheney, WA. The 
samples were diluted and plated on MacConkey agar to select for gram-negative 
bacteria. From these plates, 100 colonies of varied colony morohology were randomly 
picked and tested against seven antibiotics representing a variety of antibiotic classes. 
Drugs from six different classes that are commonly used to prevent human infections 
were selected for this study. In aminoglycoside class, kanamycin and streptomycin were 
used. In the penicillin class, ampicillin was used. Nalidixic acid was selected from the 
quinolone class. In the tetracycline class of antibiotics, tetracycline was used. Other 
antibiotics such as rifampin and chloramphenicol were also tested. Of the 100 colonies 
tested, 68% of bacteria were resistant to two or more drugs (Table 5a and 5b). Of the 68 
resistant isolates, 81% were resistant to ampicillin, 35% to kanamycin, 56% to 
streptomycin, 35% to chloramphenicol, 62% to nalidixic acid, 51% to tetracycline and 
68% to rifampin (Figure 7). Overall, many of the bacteria screened were ampicillin and 
rifampin resistant which suggests the high usage of these antibiotics in the community 
(Figure 7). Ampicillin resistant isolates frequently exhibited tetracycline, streptomycin 
and rifampin resistance which is consistent with the study of others (Mirzaagha et al., 
2009; Van Donkersgoed et al., 2003). We also found chloramphenicol resistant isolates 
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which is surprising because chloramphenicol is withdrawn in U.S based on their toxic 
effects. Macrolide antibiotics such as erythromycin inhibits protein synthesis by binding 
to 50S ribosomal subunit similar to chloramphenicol. Erythromycin resistant isolates 
have been isolated and identified from Cheney waste water facility (Marshall, 2009). 
This could be the reason for the presence of chloramphenicol resistance among 
bacteria. In addition, studies show resistance (R) plasmid that confer ampicillin and 
tetracycline resistance frequently confer chloramphenicol resistance (Haldar et al., 
1995; Mandal et al., 2005). We found many ampicillin and tetracycline resistant isolates 
which also carried plasmid, so this might have conferred chloramphenicol resistance in 
bacteria. Of the 68 resistant isolates, 17.6% were resistant to two drugs, 20.5% to three 
drugs, 26.4% to four and five drugs and finally 8.8% were resistant to six drugs. None of 
the isolates were resistant to all the drugs tested (Figure 8). In this study, we found 
bacteria that were resistant to penicillin, tetracycline and quinolone class of antibiotics 
which is consistent with the previous reports (Marshall, 2009).  
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Table 5a: Resistance profile of the isolates X1-X36 
Isolate # Amp Kan Str Chl Nal Tet Rif 
X1 + - + - + + - 
X2 + + + - - + + 
X3 + - - + - - + 
X4 + + + - + + - 
X5 + + + + + + - 
X6 + - - - - - + 
X7 + - - + - + - 
X8 + - + + + - + 
X9 + - + - - - + 
X10 + - - + - - + 
X11 + - + - + + - 
X12 + + - + + - - 
X13 + - - + - - + 
X14 + + - + - - + 
X15 + - - - + - + 
X16 + - + - - + - 
X17 + - - - - + + 
X18 + - - - + - + 
X19 + - - - + - - 
X20 + - + + + - + 
X21 - - + - - - + 
X22 + - + - - + + 
X23 + - + + - + + 
X24 + - + - - + + 
X25 + + + - - + + 
X26 + - - + - - - 
X27 + - + - - + + 
X28 + - + + - + + 
X29 + - - - - - + 
X30 + - + + + + - 
X31 + + + - - + + 
44 
 
X32 + + - - - + + 
X33 + + + + - + + 
X34 + + + - + + + 
X35 + - + - + + - 
X36 + - + - - + + 
 
 
Table 5b: Resistance profile of the isolates X37-X68 
Isolate # Amp Kan Str Chl Nal Tet Rif 
X37 + + - - + + + 
X38 - - + - + - - 
X39 + - - - + + + 
X40 + + - - + - + 
X41 + - + - + + + 
X42 + + - + + - + 
X43 + + - - + - + 
X44 + + + + + - + 
X45 + + + + + - + 
X46 + + - - + - - 
X47 + + + - + - - 
X48 + + + +  - + 
X49 + + + - + - + 
X50 + - + - + + + 
X51 - - - - + - + 
X52 - - + + + + + 
X53 + - + - - - + 
X54 + + + + + - + 
X55 - - - + + - - 
X56 + - + - + + + 
X57 - + + + + - - 
X58 - - + - - - + 
X59 - - - - + + - 
X60 - + + + + + - 
X61 - - - - + + + 
X62 + - - - + + + 
X63 - - - - + + - 
X64 + - + - + + - 
X65 - - - + + + - 
X66 + - - - + + + 
X67 + - - - + - + 
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X68 - + - - + - - 
 
 
 
 
 
 
Figure 7: The graph represents the percent of isolates that were resistant to different 
antibiotics.  
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Figure 8: The graph represents the percent of isolates that were resistant to a given number of 
the antibiotics tested.  
 
 
 
 
     We did not do any correlation study regarding the usage of antibiotics by the local 
community and the presence of drug resistant bacteria in Cheney biosolids. Former 
student in our lab took survey from three pharmacies in Cheney local, and tried to do 
some correlation study (Marshall, 2009). However, she was not able to correlate the 
antibiotics sold by local pharmacies with the drug resistant bacteria present in Cheney 
biosolids (Marshall, 2009). Many people in Cheney commute to Spokane every day and 
vice versa, so they could obtain antibiotics from pharmacies outside the city limit. It is 
difficult to survey the amount of prescription antibiotics sold by all these pharmacies 
because of privacy issues. Amount of resistant bacteria and unadsorbed antibiotics 
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excreted by the people can also vary (Sarmah et al., 2006). For these reasons, antibiotics 
that are commonly used by people are chosen for this study. 
 
 
 
 
 
 
 
 
 
 
 
 
3.2 Isolation of Plasmids from Resistant Bacteria: 
     Multi-drug resistant bacteria are more likely to carry resistance plasmids (Nikaido, 
2009; Maruyama et al., 2006). To verify this possibility, plasmids were extracted from all 
the 68 resistant isolates X1 to X68 (data not shown here). Prior to plasmid extraction, 
resistant isolates were once again streaked on antibiotic plates to ensure their drug 
resistance (Figure 9). Using the manufacturer’s protocol of plasmid isolation kit, 
plasmids were isolated, and their size and yield were determined on a 0.7% agarose gel. 
There were nine isolates X3, X9, X11, X16, X41, X52, X53, X58 and X66 that showed the 
presence of plasmids (Figure 10a, 10b and Table 6). Here, we showed that multi-drug 
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resistant bacteria carried resistance plasmid which is consistent with other studies 
(Bergstrom et al., 2000; Kruse and Sorum, 1994; Nikaido 2009). There are two possible 
ways to explain the absence of plasmids in the remaining resistant isolates. One, the 
resistant bacteria carry resistance genes on their chromosome. It has been shown that 
drug resistance genes are often encoded on the bacterial chromosome (Carattoli, 2001; 
Drlica and Malik, 2003; Sharma and Mohan, 2006). Second, the resistant bacteria might 
have carried large molecular weight plasmids which were not processed in this assay. 
The plasmid preparation kit used was suitable for smaller size plasmids (<20 kb), so 
plasmids larger than that might not be isolated (Fermentas Life Sciences, Irvine, CA).  
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Figure 9: Antibiotic sensitivity testing of the isolates. At the top from left to right: the plates 
contain ampicillin, rifampin, kanamycin and tetracycline. At the bottom from left to right: the 
plates contain chloramphenicol, streptomycin and nalidixic acid. These antibiotic plates serve as 
a model to represent the sensitivity of bacteria to various drugs. 
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Figure 10a: Agarose gel showing the 
presence of plasmids.  
Lane C-, E.coli DH5α lacking a 
plasmid. Lane L is a supercoiled DNA 
ladder. Lane C+, E.coli MM294 
containing pGLO plasmid. Lanes X3, 
X9, X11, X16 and X41 are the 
isolates that showed the presence 
of plasmids. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10b: Agarose gel showing the 
presence of plasmids.  
Lane C-, E.coli DH5α lacking a plasmid. 
Lane L is a supercoiled DNA ladder. 
Lane C+, E.coli MM294 containing 
pGLO plasmid. Lanes X52, X53, X58 
and X66 are the isolates that showed 
the presence of plasmids.  
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3.3 Identification of Resistant Bacteria: 
     The nine isolates (X3-I, X9-I, X11-I, X16-I, X41-I, X52-I, X53-I, X58-I and X66-I) that 
showed the presence of plasmids were identified using the API identification scheme 
(Figure 11) and oxidase test. The three isolates (X3-I, X52-I and X58-I) were identified as 
Escherichia coli,  two isolates (X9-I and X66-I) as Salmonella spp and two isolates (X16-I 
and X53-I) as Kluyvera spp. There was one isolate (X11-I) identified as Enterobacter 
aerogenes. Finally, the remaining isolate (X41-I) could be either Klebsiella pnuemoniae 
or Klebsiella planticola. These data are summarized in Table 6. The isolates were 
identified based on some important biochemical tests. For instance, E. coli isolates were 
positive for indole production, beta-galactosidase and ornithinine decarboxylase 
reactions. The Klebsiella pnuemoniae isolates were positive for citrate utilization, urea 
hydrolysis and acetoin production. Similarly, Kluyvera isolates were positive for indole 
production, citrate utilization and glucose oxidation; the Salmonella isolates were 
positive for ornithinine decarboxylase and hydrogen sulfide production. Finally, the 
Enterobacter aerogenes  was positive for citrate utilization, ornithinine decarboxylase 
and acetoin production. None of the isolates were positive for the oxidase test 
confirming that these isolates truly belong to Enterobacteriaceae family.    
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Figure 11: API-20E strips used for the identification of bacteria. At the top is the isolate X58-I 
identified as E.coli. At the middle is an isolate X16-I identified as Kluyvera spp. At the bottom: 
the isolate X11-I identified as Enterobacter aerogenes.  
 
Table 6: Identity of resistant bacteria and their antibiotic resistance profile 
Isolate # Antibiotic Resistance API Identification 
X3-I Amp, Chl, Rif E.coli  
X9-I Amp, Str, Rif Salmonella spp.  
X11-I Amp, Str, Nal, Tet Enterobacter aerogenes  
X16-I Amp, Str, Tet Kluyvera spp.  
X41-I Amp, Str, Nal, Tet, Rif 
K.pnueumoniae 
/K.planticola 
 
X52-I Str, Nal, Tet, Rif, Chl E.coli  
X53-I Amp, Str, Rif Kluyvera spp.  
X58-I Str, Rif E.coli  
X66-I Amp, Tet, Nal, Rif Salmonella spp.  
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     The API and oxidase test results indicated that all the bacteria identified (E.coli, 
Salmonella, Enterobacter, Kluyvera and Klebsiella) belong to Enterobacteriaceae family 
which is consistent with the results of others (Hoyle et al., 2005; Van Donkersgoed et al., 
2003). Studies show that members of the Enterobacteriaceae family are frequently 
found in sewage samples because many of them are present in the human and animal 
gastro-intestinal tract (Hoyle et al., 2005; Van Donkersgoed et al., 2003). A correlation 
between antimicrobials used and the development of drug resistance in E.coli has been 
well documented (Van den Bogaard and Stobberingh, 2000). It has been shown that 
resistance determinants can be transferred from E.coli to enteric pathogens (Aslam and 
Service, 2006; Blake et al., 2003). In this study, we identified multidrug resistant E.coli 
and other organisms. Many of these multidrug resistant organisms carried plasmid 
which is in agreement with the previous reports (Bergstrom et al., 2000; Nikaido 2009). 
Furthermore, it has been reported that conjugative plasmids encoding multidrug 
resistance genes could be responsible for the transfer of resistance among 
Enterobacteriaceae (Paterson, 2006 and Poppe et al., 2001). 
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3.4 Transformation: 
     Transformation was performed to identify the location of resistance genes. Plasmids 
isolated from nine isolates (X3-I, X9-I, X11-I, X16-I, X41-I, X52-I, X53-I, X58-I and X66-I) 
were introduced into E.coli MM294 (Figure 10a and 10b). These 9 plasmids are referred 
to as ‘parental plasmids’ in this work. The bacterial colonies formed on the antibiotic 
plates represent transformants that took the plasmid DNA. Of the 9 plasmid isolates, 
only 7 plasmids (77.7%) were successfully and experimentally introduced into E.coli 
MM294 (Table 7). The transformation efficiency of these seven isolates was in the range 
of 6.7 X 102 to 4.7 X 103 colony forming units per microgram of DNA (shown in Table 7). 
Based on transformation results, it is clear that tetracycline, ampicillin, streptomycin, 
nalidixic acid and rifampin resistance is carried on a plasmid (Table 7) which is consistent 
with other studies (Roberts, 2006). The resistance of these transformants was 
reconfirmed by streaking them on the appropriate antibiotic plates. Plasmids were then 
reisolated from 2-3 randomly selected transformants, and their presence was confirmed 
on an agarose gel (Figure 12a – 12f).   
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Table 7: Transformation efficiency of Parental Plasmids  
Transformant 
Isolate # 
Growth of Transformants 
on Antibiotic Plates No of Transformants / μg DNA 
X3-II No growth - 
X9-II Amp 3.4 X 𝟏𝟎𝟑 
X11-II Str, Tet 
 
Str – 1.7 X 𝟏𝟎𝟑 
Tet – 3.4 X 𝟏𝟎𝟑 
 
X16-II Tet 3.2 X 𝟏𝟎𝟑 
X41-II Rif 7.4 X 𝟏𝟎𝟐 
X52-II Nal, Str, Tet 
 
Nal - 6.7 X 𝟏𝟎𝟐 
Str – 3.7 X 𝟏𝟎𝟑 
Tet – 4.7 X 𝟏𝟎𝟑 
 
X53-II Rif 6.7 X 𝟏𝟎𝟐 
X58-II No growth - 
X66-II Tet 3.0 X 𝟏𝟎𝟑 
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Figure 12a: A comparison 
between plasmids isolated 
from transformants with 
parental plasmids.   
Lane C- is E.coli MM294 
lacking a plasmid. Lane 2 is a 
parental X9-I plasmid. Lanes 
3, 4 and 5 are E.coli 
transformants taken from an 
Ampicillin plate. Lane L is a 
supercoiled ladder. Lanes 7 is 
a parental X53-I plasmid. 
Lanes 8 and 9 are E.coli 
transformants taken from 
from a Rifampin plate. Lane 
C+ is E.coli MM294 
transformed with pGLO 
plasmid.  
 
 
 
 
 
Figure 12b: A comparison 
between plasmids isolated 
from transformants with 
parental plasmids.   
Lane C- is E.coli MM294 
lacking a plasmid. Lane 2 is a 
parental X11-I plasmid. Lanes 
3, 4, 5 and 7 are E.coli 
transformants taken from a 
Streptomycin plate. Lane L is a 
supercoiled ladder. Lanes 8 
and 9 are E.coli transformants 
taken from a Tetracycline 
plate. Lane C+ is E.coli MM294 
transformed with pGLO 
plasmid.  
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Figure 12c: A comparison 
between plasmids isolated 
from transformants with 
parental plasmids.   
Lane C- is E.coli MM294 
lacking a plasmid. Lane 2 is a 
parental X41-I plasmid. Lanes 
3, 4 and 5 are E.coli 
transformants taken from a 
Rifampin plate. Lane L is a 
supercoiled ladder. Lanes 7 is a 
parental X52-I plasmid. Lane 8 
is E.coli transformants taken 
from a Nalidixic acid plate. 
Lane C+ E.coli MM294 
transformed with pGLO 
plasmid.  
 
 
 
 
 
 
 
Figure 12d: A comparison 
between plasmids isolated 
from transformants with 
parental plasmids.   
Lane C- is E.coli MM294 lacking 
a plasmid. Lane 2 is a parental 
X52-I plasmid. Lanes 3 and 5 
are E.coli transformants taken 
from a Tetracycline plate. Lane 
L is a supercoiled ladder. Lanes 
6, 7 and 8 are E.coli 
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transformants taken from a Streptomycin 
plate.  
 
 
 
Figure 12e: A comparison between 
plasmids isolated from transformants 
with parental plasmids.   
Lane C- is E.coli MM294 lacking a plasmid. 
Lane 2 is a parental X16-I plasmid. Lanes 3 
and 4 are E.coli transformants taken from 
a Tetracycline plate. Lane L is a 
supercoiled ladder. Lane C+ is E.coli 
MM294 transformed with pGLO plasmid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12f: A comparison between 
plasmids isolated from transformants with 
parental plasmids.   
Lane C- is E.coli MM294 lacking a plasmid. 
Lane 2 is a parental X66-I plasmid. Lanes 3 
and 4 are E.coli transformants taken from a 
59 
 
Tetracycline plate. Lane L is a supercoiled ladder. Lane C+ is E.coli MM294 transformed with 
pGLO plasmid.  
 
     The transformants (X9-II, X11-II, X16-II, X41-II, X52-II, X53-II and X66-II) showed 
resistance patterns similar to the parental strains (Table 6 and 7). For instance, the 
parent (X11-I) was resistant to four drugs: ampicillin, streptomycin, nalidixic acid, 
tetracycline whereas the transformant (X11-II) was resistant to streptomycin and 
tetracycline. That means, the streptomycin and tetracycline resistance were carried on a 
plasmid. These two resistance genes could be carried on a same plasmid or two 
different plasmids (Table 6 and 7). Similarly, X41-I was resistant to five drugs: ampicillin, 
streptomycin, nalidixic acid, tetracycline and rifampin. However, the transformant X41-II 
carried rifampin resistance on a plasmid (Table 6 and 7). The remaining or missing 
resistance might be carried on a chromosome. Many of the plasmids extracted from 
transformants (X41-IIr, X52-II and X16-IIt) migrated at the same distance as parental 
plasmids on a gel (Figure 12c, 12d and 12e). There were few exceptions; plasmids X9-IIa, 
X11-IIs and X66-IIt extracted from transformants migrated faster than the parental 
plasmids (Figure 12a, 12b and 12f). This is not surprising because E. coli will take only 
limited amount of DNA during transformation, and it is unlikely that E. coli take more 
than one plasmid. The different migration patterns of  parent and transformants on the 
gel could be because E. coli took only one plasmid eventhough the parent contained 
multiple plasmids. Some of the transformants showed the presence of multiple plasmids 
with different sizes on a gel. The multiple plasmid bands may reflect the presence of 
plasmid in isomeric forms such as supercoiled, relaxed and nicked (Schmidt et al., 1999). 
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To check whether these are truly different forms of a plasmid, we performed restriction 
digestion which is described in the next section (Figure 13a – 13g). The plasmids from 
two isolates (X3-I and X58-I) failed to transform in the E.coli strain. There could be a 
reason for that. The resistance genes might not be present on plasmids which prevented 
E.coli from growing on antibiotic plates. These two isolates might have carried 
resistance genes on the bacterial chromosome.  
3.5 Restriction Digestion: 
     Restriction digestion was performed to verify whether the multiple DNA bands 
represent a single plasmid in different forms. It has been shown that plasmids exist in 
various forms and the supercoiled plasmid moves much faster than the linear and 
nicked plasmids on an agarose gel (Schmidt et al., 1999). As mentioned in the previous 
section, seven out of nine plasmid preparations successfully produced transformants. 
These seven isolates were cross checked on antibiotic plates, and plasmids were 
extracted from them. These plasmids were further digested with the Type II restriction 
enzyme, EcoRI. Many of the isolates X9-II, X11-II, X16-II, X41-II, X52-II, X53-II, X66-II 
formed single band on an agarose gel after digestion with EcoRI, suggesting these 
plasmids contained a single EcoRI restriction site (Figure 13a, 13c, 13d, 13e, 13f and 
13g). Only exception was X11-II, it formed 3 to 4 bands of smaller size than the original 
plasmid (Figure 13b). This is not surprising because an EcoRI site is predicted to occur 
once every ~4000 bp, and the size of parental plasmid was estimated to be >10 Kb, so it 
might have resulted in multiple small fragments.  
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Figure 13a: Restriction digestion of the plasmids extracted from transformants.  
Lane 1 is an undigested plasmid, pBR322. Lane 2 is a plasmid pBR322 digested with EcoRI shows 
a single band as expected. Lanes 1 and 2 serve as a positive control. Lane L is a 1 Kb DNA ladder. 
Lanes 3, 5 and 7 are X9-II plasmid samples that are not subjected to any digestion. Lanes 4, 6 
and 8 are the respective plasmids from X9-II that are digested with EcoRI. 
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Figure 13b: Restriction digestion of the plasmids extracted from transformants. 
Lane L is a 1 Kb DNA ladder. Lanes 1, 3, 5 and 7 are X11-II plasmid samples that are not 
subjected to any digestion. Lanes 2, 4, 6 and 8 are the respective plasmids from X11-II that are 
digested with EcoRI. 
 
 
 
 
 
 
 
 
 
 
Figure 13c: Restriction digestion of the plasmids extracted from transformants. 
Lanes 1 and 3 are X11-II plasmid samples that are not digested. Lanes 2 and 4 are X11-II plasmid 
samples that are digested with EcoRI. Lane L is a 1 Kb DNA ladder. Lanes 5 and 7 are the 
respective plasmids from X16-II plasmid samples that are not subjected to any digestion. Lanes 6 
and 8 are the respective plasmids from 
X16-II that are digested with EcoRI.  
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Figure 13d: Restriction digestion of the 
plasmids extracted from 
transformants.  
Lanes 1, 3 and 5 are X41-II plasmid 
samples that are not digested. Lanes 2, 
4 and 6 are X41-II plasmid samples that 
are digested with EcoRI. Lane L is a 1 Kb 
DNA ladder. Lane 7 is X52-II plasmid 
sample that is not subjected to any 
digestion. Lane 8 is the respective 
plasmid from X52-II digested with 
EcoRI.  
 
 
 
 
 
 
 
 
 
 
Figure 13e: Restriction digestion of the 
plasmids extracted from 
transformants.  
Lanes 1, 3, 5 and 7 are X52-II plasmid 
samples that are not digested. Lanes 2, 
4, 6 and 8 are the respective plasmids 
from X52-II that are digested with EcoRI. 
Lane L is a 1 Kb DNA ladder.  
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Figure 13f: Restriction digestion of the plasmids 
extracted from transformants.  
Lane 1 is an undigested plasmid, pBR322. Lane 2 
is a plasmid pBR322 digested with EcoRI. Lanes 1 
and 2 serve as a positive control. Lane L is a 1 Kb 
DNA ladder. Lane 3 is an X66-II plasmid sample 
digested with EcoRI. Lane 4 is an X66-II plasmid 
sample that is not digested. Lane 5 is X66-II 
plasmid sample that is not digested. Lane 6 is the 
respective plasmid from X66-II digested with 
EcoRI.  
 
 
 
 
 
 
 
 
 
 
Figure 13g: Restriction digestion of the 
plasmids extracted from transformants.  
Lane 1 is an X52-II plasmid sample that is not 
digested. Lane 2 is an X52-II plasmid sample 
digested with EcoRI. Lane L is a 1 Kb DNA 
ladder. Lanes 3 and 5 are X53-II plasmid 
samples that are not digested. Lanes 4 and 6 
are X53-II plasmid samples that are digested 
with EcoRI. Lane 7 is an undigested plasmid, 
pBR322. Lane 8 is a plasmid pBR322 digested 
with EcoRI. Lanes 7 and 8 serve as a positive 
control. 
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3.6 Phage Sensitivity Testing:  
     Coliphages such as Qβ and M13 are known to infect E.coli strains carrying conjugative 
plasmids (Long et al., 2005; Sobsey et al., 1995). The nine isolates X3-I, X9-I, X11-I, X16-I, 
X41-I, X52-I, X53-I, X58-I and X66-I that showed the presence of plasmids were tested 
for the presence of conjugative plasmids using coliphages. The Qβ and M13 phages 
infect through conjugation pilus formed by the bacteria, so if the bacteria are infected, 
they have conjugative genes either on the plasmid or genomic DNA. Based on this 
concept, the nine isolates were tested for the sensitivity to Qβ and M13 phages. The 
natural host for Qβ and M13 phages are E.coli. Three E.coli isolates X3-I, X52-I and X58-I 
that showed the plasmid presence were tested for conjugative plasmid, but none of 
them were infected by the coliphages (Figure 14). We also tested other isolates (non E. 
coli) that showed plasmid presence even though they are not the natural host for these 
phages. As expected, none of them were infected (data not shown here).  
     There could be two reasons for the isolates not being infected. First, all these 
plasmids might not be conjugative; i.e. these isolates were not able to form conjugation 
pilus. Second, even if the plasmids were conjugative, the conjugative function was 
repressed for some reason. It has been shown that conjugative plasmids may carry 
fertility inhibition factor or fin genes which are able to suppress the formation of 
conjugation pilus in order to prevent infection caused by bacteriophages (Haft et al., 
2009). Conjugation adds stress to the host bacteria and these bacteria tend to grow 
relatively slowly compared to the one without conjugation factors. The fertility 
inhibition helps the host cells to multiply rapidly and dominate the population, so the fin 
67 
 
genes are turned on to reduce the cost to the host bacterium (Haft et al., 2009; Mc 
Ginty and Rankin, 2012). Therefore, it could be possible that the E.coli isolates we tested 
might have carried fin genes which prevented them from being infected by Qβ and M13 
phages. 
 
 
Figure 14: Phage sensitivity testing. On the left is a positive control, E.coli XK1502 infected with 
two phages: M13 and Qβ. The visible clearing or plaque formation on the lawn of bacteria 
represents the sensitivity of this bacteria to the phages. On the right is a negative control, E.coli 
MC4100 infected with the same phages but no plaques are produced. At the bottom is an 
isolate E.coli X52-I infected with the same phages. The absence of plaque formation indicates 
this isolate was not able to form conjugation pilus.  
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3.7 Tripartite Mating:  
     Tripartite mating was performed to identify mobilizable plasmids. This mating 
process requires three strains: a donor, a helper and a recipient. The donor may carry 
mobilizable plasmid but is incapable of forming conjugation pilus because of the 
absence of tra gene function. The helper will provide the missing tra function to the 
donor, so the donor will form conjugation pilus and transfer their gene to the recipient 
(Droge et al., 2000; Schluter et al., 2007). By this assay, mobilizable plasmids can be 
identified.  
     As mentioned in a previous section, the isolate E.coli X3-I was tested for the presence 
of conjugative plasmid using the phage sensitivity assay, but it was negative for 
conjugative plasmid. Before tripartite mating, the isolate X3-I was plated with the 
recipient to reconfirm the absence of conjugative plasmid (data not shown here). After 
reconfirmation, tripartite mating was performed with the isolate (X3-I) to identify the 
presence of mobilizable plasmid. The donor was resistant to 3 drugs (ampicillin, rifampin 
and chloramphenicol), the helper was nalidixic acid resistant, and the recipient was 
resistant to streptomycin (Figure 15a and 15b). The antibiotic plates were made in all 
different combinations of these 5 drugs, and each plate was divided into four sections: 
(1) donor alone, (2) recipient alone, (3) helper alone, and (4) recipient + donor + helper. 
Section 4 represents tripartite mating in which the donor isolate E.coli X3-I is plated 
together with the helper and recipient E.coli on all different antibiotic plates (Figure 15a 
and 15b). If the donor (X3-I) carried mobilizable plasmid, it will transfer the resistance 
plasmid to the recipient and form colonies on the antibiotic plates. Unfortunately, this 
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isolate did not form a transconjugant or bacterial colony on any of the antibiotic plates, 
so the donor lacks both the conjugative and mobilizable plasmids (Figure 15a and 15b). 
We tested only this isolate (X3-I) because it has a resistance marker different from the 
helper and recipient. We are not able to test other isolates because they are multi-drug 
resistant and carried the same resistance marker like the helper and recipient. If we test 
these isolates using the same procedure, then we would not be able to distinguish 
between the donor, helper and recipient. We had a trouble finding a strain that has a 
resistance marker different from the donor. Many of the strains available in CGSC and 
ATCC bacterial strain banks were not helpful because they carried the same resistance 
marker as the donor. We did not test the other isolates because of these complications.  
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             Figure 15a: Resistance profile of the donor, helper and recipient strains. The donor 
isolate X3-I is resistant to ampicillin, rifampin and chloramphenicol. The helper is resistant to 
nalidixic acid and the recipient is resistant to streptomycin. These antibiotics plates serve as a 
positive control for tripartite mating process and confirm the resistance pattern of the strains. 
 
 
Figure 15b: Tripartite mating process. As mentioned in Fig 9a, the donor was resistant to 3 
drugs, and both helper and recipient were resistant to one drug, so antibiotic plates were made 
in all different combinations of these 5 drugs. Each plate was divided into four sections: (1) 
donor alone, (2) recipient alone, (3) helper alone, and (4) recipient + donor + helper. Section 4 
represents tripartite mating in which the donor isolate E.coli X3-I is plated together with the 
helper and recipient E.coli on all different antibiotic plates. None of them resulted in colony 
formation, so this isolate is neither conjugative nor mobilizable type.  
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4. Conclusions: 
     Biosolids are used as fertilizer in agricultural crops and home gardens all over the 
United States, but there is great concern regarding their application. It has been shown 
that antibiotics persist in the environment for a long time and reach ground water or 
aquatic sediments through application of liquid manure or sewage sludge as fertilizers 
(Kuhne et al., 2001; Kummerer, 2001). Antibiotics present in sewage select resistant 
bacteria, and there is increased risk of spreading drug resistance genes among members 
of bacterial community. Previous studies have shown that application of manure as 
fertilizer is unsafe because it can act as a reservoir for pathogens carrying drug 
resistance plasmids (Binh et al., 2008). In addition, viruses present in sewage are 
maintained because they are more resistant to ammonia and heat treatments (Lund et 
al., 1996). These studies show that biosolids contain resistant bacteria and viruses that 
can transfer their resistance genes to other bacteria. Currently, biosoilds are tested only 
for the indicator organisms such as fecal coliforms, but it is better to test the biosolids 
for the presence of drug resistant bacteria, human viruses and bacteriophages. Such 
studies should be carried out to avoid the risks of contaminating garden and agricultural 
soils with pathogens and to reduce infections in humans and animals. Alternately, the 
biosolids should be sterilized before being sold as fertilizer or soil conditioner.  
     The purpose of my study was to determine the presence of drug resistant bacteria 
and resistance (R) plasmids in Cheney biosolids. We identified bacteria (68%) were 
resistant to two or more drugs tested and many of these resistant bacteria (13.2%) 
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carried resistance plasmids. The R-plasmids were able to transfer successfully to a 
laboratory strain of E.coli. The resistant bacteria (13.2%) were tested for the presence of 
conjugative plasmid using Qβ and M13 phages, but none of the bacteria were 
conjugative type. In addition, resistant bacteria (13.2%) were tested for the presence of 
mobilizable plasmid by tripartite mating, but none of the bacteria were mobilizable type. 
As a result, the resistant bacteria tested were neither conjugative nor mobilizable type.  
     One of the obstacles for conjugation and tripartite mating is the availability of a 
suitable recipient bacteria with unique resistance marker. This problem can be solved by 
developing a unique recipient using recombinant DNA techniques. The presence of 
conjugative and mobilizable plasmids in biosolids can be further analysed by relaxase 
screening method (Alvarado et al., 2012). The biosolids should be tested further for the 
presence of enteric viruses of health concern either by monitoring the presence of 
bacteriophages using PCR techniques (Fout et al., 2003; Sobsey et al., 1995). In 
conclusion, Cheney biosolids do contain drug resistant bacteria despite of all the waste 
water treatment processes, so it is better to enhance treatment regulations to avoid 
serious health effects.  
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